| WFP | Name: | 3,5-difluoro-L-phenylalanine | Formula: | C9 H9 F2 N O2 | SMILES: | N[CH](Cc1cc(F)cc(F)c1)C(O)=O | InChi: | InChI=1S/C9H9F2NO2/c10-6-1-5(2-7(11)4-6)3-8(12)9(13)14/h1-2,4,8H,3,12H2,(H,13,14)/t8-/m0/s1 | Definition date: | 2009-12-13 | Last modified: | 2024-09-27 | Identifier: | (2S)-2-azanyl-3-(3,5-difluorophenyl)propanoic acid |
|
| UPQ | Name: | 4-(4-methylimidazol-1-yl)benzaldehyde | Formula: | C11 H10 N2 O | SMILES: | Cc1cn(cn1)c2ccc(C=O)cc2 | InChi: | InChI=1S/C11H10N2O/c1-9-6-13(8-12-9)11-4-2-10(7-14)3-5-11/h2-8H,1H3 | Definition date: | 2021-03-04 | Last modified: | 2024-09-27 | Release date: | 2021-06-16 | Identifier: | 4-(4-methylimidazol-1-yl)benzaldehyde |
|
| T3V | Name: | 1-{4-[(2-fluorophenyl)sulfonyl]piperazin-1-yl}ethan-1-one | Formula: | C12 H15 F N2 O3 S | SMILES: | N2(CCN(S(c1ccccc1F)(=O)=O)CC2)C(=O)C | InChi: | InChI=1S/C12H15FN2O3S/c1-10(16)14-6-8-15(9-7-14)19(17,18)12-5-3-2-4-11(12)13/h2-5H,6-9H2,1H3 | Definition date: | 2020-03-16 | Last modified: | 2024-09-27 | Release date: | 2020-03-25 | Identifier: | 1-{4-[(2-fluorophenyl)sulfonyl]piperazin-1-yl}ethan-1-one |
|
| XD1 | Name: | (2R,4S)-2-[(1R)-1-amino-2-oxoethyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid | Formula: | C8 H14 N2 O3 S | SMILES: | O=C(O)C1NC(SC1(C)C)C(N)C=O | InChi: | InChI=1S/C8H14N2O3S/c1-8(2)5(7(12)13)10-6(14-8)4(9)3-11/h3-6,10H,9H2,1-2H3,(H,12,13)/t4-,5+,6-/m1/s1 | Synonyms: | 6-aminopenicillian, bound form | Definition date: | 2010-06-08 | Last modified: | 2024-09-27 | Identifier: | (2R,4S)-2-[(1R)-1-amino-2-oxoethyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid |
|
| V4F | Name: | 8-(aminomethyl)-4-(phosphonomethoxy)quinoline-2-carboxylic acid | Formula: | C12 H13 N2 O6 P | SMILES: | NCc1cccc2c(OC[P](O)(O)=O)cc(nc12)C(O)=O | InChi: | InChI=1S/C12H13N2O6P/c13-5-7-2-1-3-8-10(20-6-21(17,18)19)4-9(12(15)16)14-11(7)8/h1-4H,5-6,13H2,(H,15,16)(H2,17,18,19) | Definition date: | 2023-02-21 | Last modified: | 2024-09-27 | Release date: | 2023-07-19 | Identifier: | 8-(aminomethyl)-4-(phosphonomethoxy)quinoline-2-carboxylic acid |
|
| IWW | Name: | [(E)-ethene-1,2-diylbis(3-chloro-4,1-phenylene)]diboronic acid | Formula: | C14 H12 B2 Cl2 O4 | SMILES: | c1(cc(c(cc1)C=Cc2ccc(cc2Cl)B(O)O)Cl)B(O)O | InChi: | InChI=1S/C14H12B2Cl2O4/c17-13-7-11(15(19)20)5-3-9(13)1-2-10-4-6-12(16(21)22)8-14(10)18/h1-8,19-22H/b2-1+ | Definition date: | 2016-12-07 | Last modified: | 2024-09-27 | Release date: | 2017-09-27 | Identifier: | [(E)-ethene-1,2-diylbis(3-chloro-4,1-phenylene)]diboronic acid |
|
| XTM | Name: | N~2~-{[(3-fluorophenyl)methoxy]carbonyl}-N-{(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-L-leucinamide | Formula: | C21 H30 F N3 O5 | SMILES: | C2(=O)C(CC(NC(C(CC(C)C)NC(OCc1cccc(F)c1)=O)=O)CO)CCN2 | InChi: | InChI=1S/C21H30FN3O5/c1-13(2)8-18(25-21(29)30-12-14-4-3-5-16(22)9-14)20(28)24-17(11-26)10-15-6-7-23-19(15)27/h3-5,9,13,15,17-18,26H,6-8,10-12H2,1-2H3,(H,23,27)(H,24,28)(H,25,29)/t15-,17-,18-/m0/s1 | Definition date: | 2021-01-13 | Last modified: | 2024-09-27 | Release date: | 2022-12-07 | Identifier: | N~2~-{[(3-fluorophenyl)methoxy]carbonyl}-N-{(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-L-leucinamide |
|
| XD2 | Name: | (2R)-2-[(1R)-1-{[(2R)-2-hydroxy-2-phenylacetyl]amino}-2-oxoethyl]-5-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-3,6-dihydro-2H-1,3-thiazine-4-carboxylic acid | Formula: | C18 H20 N6 O5 S2 | SMILES: | O=CC(NC(=O)C(O)c1ccccc1)C2SCC(=C(N2)C(=O)O)CSc3nnnn3C | InChi: | InChI=1S/C18H20N6O5S2/c1-24-18(21-22-23-24)31-9-11-8-30-16(20-13(11)17(28)29)12(7-25)19-15(27)14(26)10-5-3-2-4-6-10/h2-7,12,14,16,20,26H,8-9H2,1H3,(H,19,27)(H,28,29)/t12-,14-,16-/m1/s1 | Synonyms: | Cefamandole, bound form | Definition date: | 2010-06-09 | Last modified: | 2024-09-27 | Identifier: | (2R)-2-[(1R)-1-{[(2R)-2-hydroxy-2-phenylacetyl]amino}-2-oxoethyl]-5-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-3,6-dihydro-2H-1,3-thiazine-4-carboxylic acid |
|
| V4H | Name: | 4-[(3~{R})-3-oxidanylpiperidin-1-yl]carbonylbenzaldehyde | Formula: | C13 H15 N O3 | SMILES: | O[CH]1CCCN(C1)C(=O)c2ccc(C=O)cc2 | InChi: | InChI=1S/C13H15NO3/c15-9-10-3-5-11(6-4-10)13(17)14-7-1-2-12(16)8-14/h3-6,9,12,16H,1-2,7-8H2/t12-/m1/s1 | Definition date: | 2021-04-12 | Last modified: | 2024-09-27 | Release date: | 2021-06-09 | Identifier: | 4-[(3~{R})-3-oxidanylpiperidin-1-yl]carbonylbenzaldehyde |
|
| ZV4 | Name: | (2S)-2-azanyl-3-(4-phosphonophenyl)propanoic acid | Formula: | C9 H12 N O5 P | SMILES: | N[CH](Cc1ccc(cc1)[P](O)(O)=O)C(O)=O | InChi: | InChI=1S/C9H12NO5P/c10-8(9(11)12)5-6-1-3-7(4-2-6)16(13,14)15/h1-4,8H,5,10H2,(H,11,12)(H2,13,14,15)/t8-/m0/s1 | Synonyms: | phosphophenylalanine | Definition date: | 2023-04-06 | Last modified: | 2024-09-27 | Release date: | 2023-04-19 | Identifier: | (2~{S})-2-azanyl-3-(4-phosphonophenyl)propanoic acid |
|
| XTP | Name: | benzyl [(2S)-3-cyclopropyl-1-({(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}amino)-1-oxopropan-2-yl]carbamate | Formula: | C21 H29 N3 O5 | SMILES: | C3(=O)C(CC(CO)NC(C(CC1CC1)NC(=O)OCc2ccccc2)=O)CCN3 | InChi: | InChI=1S/C21H29N3O5/c25-12-17(11-16-8-9-22-19(16)26)23-20(27)18(10-14-6-7-14)24-21(28)29-13-15-4-2-1-3-5-15/h1-5,14,16-18,25H,6-13H2,(H,22,26)(H,23,27)(H,24,28)/t16-,17-,18-/m0/s1 | Definition date: | 2021-01-13 | Last modified: | 2024-09-27 | Release date: | 2021-07-07 | Identifier: | benzyl [(2S)-3-cyclopropyl-1-({(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}amino)-1-oxopropan-2-yl]carbamate |
|
| V4K | Name: | 4-[4-(2-hydroxyethyl)piperidin-1-yl]carbonylbenzaldehyde | Formula: | C15 H19 N O3 | SMILES: | OCCC1CCN(CC1)C(=O)c2ccc(C=O)cc2 | InChi: | InChI=1S/C15H19NO3/c17-10-7-12-5-8-16(9-6-12)15(19)14-3-1-13(11-18)2-4-14/h1-4,11-12,17H,5-10H2 | Definition date: | 2021-04-12 | Last modified: | 2024-09-27 | Release date: | 2021-06-09 | Identifier: | 4-[4-(2-hydroxyethyl)piperidin-1-yl]carbonylbenzaldehyde |
|
| ZDC | Name: | 3,7-anhydro-2,8-dideoxy-L-glycero-D-gluco-octonic acid | Formula: | C8 H14 O6 | SMILES: | O=C(O)CC1OC(C(O)C(O)C1O)C | InChi: | InChI=1S/C8H14O6/c1-3-6(11)8(13)7(12)4(14-3)2-5(9)10/h3-4,6-8,11-13H,2H2,1H3,(H,9,10)/t3-,4-,6+,7+,8+/m0/s1 | Definition date: | 2012-12-17 | Last modified: | 2024-09-27 | Release date: | 2016-02-10 | Identifier: | 3,7-anhydro-2,8-dideoxy-L-glycero-D-gluco-octonic acid |
|
| T43 | Name: | 2,2,2-trifluoro-N-{(2S)-1-[(1R,2S,5S)-2-({(2S)-1-(4-fluoro-1,3-benzothiazol-2-yl)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}carbamothioyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexan-3-yl]-3,3-dimethyl-1-oxobutan-2-yl}acetamide | Formula: | C30 H35 F4 N5 O4 S2 | SMILES: | FC(F)(F)C(=O)NC(C(=O)N1CC2C(C1C(=S)NC(CC1CCNC1=O)C(=O)c1nc3c(F)cccc3s1)C2(C)C)C(C)(C)C | InChi: | InChI=1S/C30H35F4N5O4S2/c1-28(2,3)22(38-27(43)30(32,33)34)26(42)39-12-14-18(29(14,4)5)20(39)24(44)36-16(11-13-9-10-35-23(13)41)21(40)25-37-19-15(31)7-6-8-17(19)45-25/h6-8,13-14,16,18,20,22H,9-12H2,1-5H3,(H,35,41)(H,36,44)(H,38,43)/t13-,14-,16-,18-,20-,22+/m0/s1 | Definition date: | 2022-07-18 | Last modified: | 2024-09-27 | Release date: | 2022-08-24 | Identifier: | 2,2,2-trifluoro-N-{(2S)-1-[(1R,2S,5S)-2-({(2S)-1-(4-fluoro-1,3-benzothiazol-2-yl)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}carbamothioyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexan-3-yl]-3,3-dimethyl-1-oxobutan-2-yl}acetamide |
|
| SQ3 | Name: | (1R,2S,5S)-3-[(2,4-dichlorophenoxy)acetyl]-N-{(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide | Formula: | C23 H29 Cl2 N3 O5 | SMILES: | CC1(C)C2C(C(=O)NC(CC3CCNC3=O)CO)N(CC21)C(=O)COc1ccc(Cl)cc1Cl | InChi: | InChI=1S/C23H29Cl2N3O5/c1-23(2)15-9-28(18(30)11-33-17-4-3-13(24)8-16(17)25)20(19(15)23)22(32)27-14(10-29)7-12-5-6-26-21(12)31/h3-4,8,12,14-15,19-20,29H,5-7,9-11H2,1-2H3,(H,26,31)(H,27,32)/t12-,14-,15-,19-,20-/m0/s1 | Definition date: | 2023-08-28 | Last modified: | 2024-09-27 | Release date: | 2024-08-28 | Identifier: | (1R,2S,5S)-3-[(2,4-dichlorophenoxy)acetyl]-N-{(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide |
|
| T44 | Name: | 3,5,3',5'-TETRAIODO-L-THYRONINE | Formula: | C15 H11 I4 N O4 | SMILES: | O=C(O)C(N)Cc2cc(I)c(Oc1cc(I)c(O)c(I)c1)c(I)c2 | InChi: | InChI=1S/C15H11I4NO4/c16-8-4-7(5-9(17)13(8)21)24-14-10(18)1-6(2-11(14)19)3-12(20)15(22)23/h1-2,4-5,12,21H,3,20H2,(H,22,23)/t12-/m0/s1 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-L-tyrosine |
|
| TXH | Name: | ~{tert}-butyl ~{N}-[(2~{S})-3-(1~{H}-indol-3-yl)-1-(2-methanoylhydrazinyl)-1-oxidanylidene-propan-2-yl]carbamate | Formula: | C17 H22 N4 O4 | SMILES: | CC(C)(C)OC(=O)N[CH](Cc1c[nH]c2ccccc12)C(=O)NNC=O | InChi: | InChI=1S/C17H22N4O4/c1-17(2,3)25-16(24)20-14(15(23)21-19-10-22)8-11-9-18-13-7-5-4-6-12(11)13/h4-7,9-10,14,18H,8H2,1-3H3,(H,19,22)(H,20,24)(H,21,23)/t14-/m0/s1 | Definition date: | 2023-01-13 | Last modified: | 2024-09-27 | Release date: | 2023-01-25 | Identifier: | ~{tert}-butyl ~{N}-[(2~{S})-3-(1~{H}-indol-3-yl)-1-(2-methanoylhydrazinyl)-1-oxidanylidene-propan-2-yl]carbamate |
|
| WFZ | Name: | 2-[2-(1-azanylethenyl)-1,3-thiazol-4-yl]-6-(4-methoxycarbonyl-1,3-thiazol-2-yl)pyridine-3-carboxylic acid | Formula: | C16 H12 N4 O4 S2 | SMILES: | COC(=O)c1csc(n1)c2ccc(C(O)=O)c(n2)c3csc(n3)C(N)=C | InChi: | InChI=1S/C16H12N4O4S2/c1-7(17)13-19-10(5-25-13)12-8(15(21)22)3-4-9(18-12)14-20-11(6-26-14)16(23)24-2/h3-6H,1,17H2,2H3,(H,21,22) | Definition date: | 2023-10-03 | Last modified: | 2024-09-27 | Release date: | 2024-03-27 | Identifier: | 2-[2-(1-azanylethenyl)-1,3-thiazol-4-yl]-6-(4-methoxycarbonyl-1,3-thiazol-2-yl)pyridine-3-carboxylic acid |
|
| V4N | Name: | (5-methanoyl-2-nitro-phenyl) 3-chloranylbenzoate | Formula: | C14 H8 Cl N O5 | SMILES: | [O-][N+](=O)c1ccc(C=O)cc1OC(=O)c2cccc(Cl)c2 | InChi: | InChI=1S/C14H8ClNO5/c15-11-3-1-2-10(7-11)14(18)21-13-6-9(8-17)4-5-12(13)16(19)20/h1-8H | Definition date: | 2021-04-12 | Last modified: | 2024-09-27 | Release date: | 2021-06-09 | Identifier: | (5-methanoyl-2-nitro-phenyl) 3-chloranylbenzoate |
|
| TXI | Name: | (2R)-N-(4-chloro-3-oxobutyl)-2,4-dihydroxy-3,3-dimethylbutanamide | Formula: | C10 H18 Cl N O4 | SMILES: | O=C(NCCC(=O)CCl)C(O)C(C)(C)CO | InChi: | InChI=1S/C10H18ClNO4/c1-10(2,6-13)8(15)9(16)12-4-3-7(14)5-11/h8,13,15H,3-6H2,1-2H3,(H,12,16)/t8-/m0/s1 | Definition date: | 2011-09-06 | Last modified: | 2024-09-27 | Identifier: | (2R)-N-(4-chloro-3-oxobutyl)-2,4-dihydroxy-3,3-dimethylbutanamide |
|
| ZDJ | Name: | 3-methyl-L-tyrosine | Formula: | C10 H13 N O3 | SMILES: | Cc1cc(CC(N)C(=O)O)ccc1O | InChi: | InChI=1S/C10H13NO3/c1-6-4-7(2-3-9(6)12)5-8(11)10(13)14/h2-4,8,12H,5,11H2,1H3,(H,13,14)/t8-/m0/s1 | Definition date: | 2021-04-15 | Last modified: | 2024-09-27 | Release date: | 2021-12-29 | Identifier: | 3-methyl-L-tyrosine |
|
| WG0 | Name: | [(6S,10P)-4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl]acetic acid | Formula: | C19 H17 Cl N4 O2 S | SMILES: | O=C(O)CC1N=C(c2ccc(Cl)cc2)c2c(C)c(C)sc2n2c(C)nnc21 | InChi: | InChI=1S/C19H17ClN4O2S/c1-9-10(2)27-19-16(9)17(12-4-6-13(20)7-5-12)21-14(8-15(25)26)18-23-22-11(3)24(18)19/h4-7,14H,8H2,1-3H3,(H,25,26)/t14-/m0/s1 | Definition date: | 2022-09-07 | Last modified: | 2024-09-27 | Release date: | 2023-10-04 | Identifier: | [(6S,10P)-4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl]acetic acid |
|
| XDD | Name: | N-[(1S,2S)-2-aminocyclopentyl]-N-[(6-amino-9H-purin-9-yl)acetyl]glycine | Formula: | C14 H19 N7 O3 | SMILES: | C(n1cnc2c1ncnc2N)C(=O)N(CC(O)=O)C3CCCC3N | InChi: | InChI=1S/C14H19N7O3/c15-8-2-1-3-9(8)21(5-11(23)24)10(22)4-20-7-19-12-13(16)17-6-18-14(12)20/h6-9H,1-5,15H2,(H,23,24)(H2,16,17,18)/t8-,9-/m0/s1 | Definition date: | 2020-12-11 | Last modified: | 2024-09-27 | Release date: | 2020-12-23 | Identifier: | N-[(1S,2S)-2-aminocyclopentyl]-N-[(6-amino-9H-purin-9-yl)acetyl]glycine |
|
| UQ1 | Name: | UBIQUINONE-1 | Formula: | C14 H18 O4 | SMILES: | O=C1C(=C(C(=O)C(OC)=C1OC)C)CC=C(/C)C | InChi: | InChI=1S/C14H18O4/c1-8(2)6-7-10-9(3)11(15)13(17-4)14(18-5)12(10)16/h6H,7H2,1-5H3 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | 2,3-dimethoxy-5-methyl-6-(3-methylbut-2-en-1-yl)cyclohexa-2,5-diene-1,4-dione |
|
| YB4 | Name: | ~{N}-(2,6-diethylphenyl)-2-[[4-(4-methylpiperazin-1-yl)-2-(propanoylamino)phenyl]amino]-5,6-dihydropyrimido[4,5-e]indolizine-7-carboxamide | Formula: | C35 H42 N8 O2 | SMILES: | CCC(=O)Nc1cc(ccc1Nc2ncc3CCc4n(ccc4C(=O)Nc5c(CC)cccc5CC)c3n2)N6CCN(C)CC6 | InChi: | InChI=1S/C35H42N8O2/c1-5-23-9-8-10-24(6-2)32(23)39-34(45)27-15-16-43-30(27)14-11-25-22-36-35(40-33(25)43)38-28-13-12-26(21-29(28)37-31(44)7-3)42-19-17-41(4)18-20-42/h8-10,12-13,15-16,21-22H,5-7,11,14,17-20H2,1-4H3,(H,37,44)(H,39,45)(H,36,38,40) | Definition date: | 2021-02-15 | Last modified: | 2024-09-27 | Release date: | 2022-02-16 | Identifier: | ~{N}-(2,6-diethylphenyl)-2-[[4-(4-methylpiperazin-1-yl)-2-(propanoylamino)phenyl]amino]-5,6-dihydropyrimido[4,5-e]indolizine-7-carboxamide |
|